Eli Lilly Balances India GLP-1 Generics Shock With Foundayo U.S. Push
Eli Lilly (NYSE:LLY) is seeing rapid market share declines in India for its GLP-1 obesity drugs as generic competitors expand following patent expirations. At the same time, Lilly is rolling out its new oral obesity pill Foundayo in the U.S. through online pharmacies, retail chains, and telehealth platforms. Foundayo is now available via Amazon Pharmacy,…
